Recent from talks
Daniel W. Nebert
Knowledge base stats:
Talk channels stats:
Members stats:
Daniel W. Nebert
Daniel Walter Nebert is an American physician-scientist. He is a professor emeritus at the University of Cincinnati College of Medicine, where he spent the latter half of his academic career. His research has revolved around the central theme of gene–environment interactions.
He is widely known for foundational research in environmental molecular genetics, pharmacogenetics, and toxicology, particularly for discovering in 1974 the first evidence for, and naming of, the aryl hydrocarbon receptor (AHR), which was first shown to regulate levels of cytochrome P450 enzymes, but which today is known to be involved in many dozens of pathways critical to life. Ultimately, his pioneering work on the AHR receptor laid the foundation for modern ecogenetics, the study of how genetic variation dictates an individual's unique physiological responses to environmental toxicants and chemicals.
Nebert was raised in Oregon and comes from a family of Austrian-Bohemian ancestry. During his youth, he developed interests in science, music, golf, and academics, including piano training, song-writing, and participation in school publications and athletics, which he has later cited as formative influences on his disciplined scientific approach.
Nebert attended Wesleyan University, where he graduated with a Bachelor of Arts in Biochemistry. He then entered a five-year combined graduate and medical track at the University of Oregon Medical School, earning a Master of Science in Biophysics and a Doctor of Medicine in 1964. Following medical school, he completed a pediatric internship and residency at the University of California, Los Angeles (UCLA) Health Sciences Center from 1964 to 1966. Nebert subsequently served as a postdoctoral fellow from 1966 to 1968 at the National Cancer Institute, a component of the National Institutes of Health (NIH) in Bethesda, Maryland, where his research focused on oncology and cancer mechanisms.
Nebert began his independent scientific career at the National Institutes of Health (NIH) when he joined the National Institute of Child Health and Human Development (NICHD) in 1968. During his more than two decades at the NIH, he served as a section head and was later appointed Chief of the Laboratory of Developmental Pharmacology. While at the institute, Nebert conducted pioneering research on the genetic regulation of drug-metabolizing enzymes, establishing early experimental frameworks for studying how environmental chemicals interact with inherited genetic variation. To help formalize this emerging field, he organized and hosted a series of major international scientific symposia on drug-metabolizing enzymes and gene-environment interactions in 1985, 1987, and 1989.
In 1989, Nebert relocated to the University of Cincinnati Medical Center, where he was appointed Professor of Environmental Health. He also held a dual appointment as an adjunct professor in the Division of Human Genetics at the Cincinnati Children’s Hospital Medical Center. At the University of Cincinnati, Nebert founded the Center for Environmental Genetics (CEG) in 1992, serving as its director.The CEG became the first National Institute of Environmental Health Sciences (NIEHS)-designated Center of Excellence dedicated specifically to environmental genetics research, fostering interdisciplinary collaboration among geneticists, toxicologists, epidemiologists, and clinicians. Nebert remained active in research and institutional leadership at Cincinnati for 24 years until transitioning to professor emeritus status in 2013.
Nebert’s research has focused broadly on gene–environment interactions, establishing him as a foundational figure in ecogenetics. His laboratory was among the first to clone and characterize genes encoding cytochrome P450 enzymes, including CYP1A1, and to demonstrate how these genes are regulated by environmental exposures through the aryl hydrocarbon receptor (AHR). Nebert discovered the first experimental evidence for, and subsequently named, the AHR receptor in 1974. While initially shown to regulate cytochrome P450 levels, the receptor is now recognized as a critical regulator in dozens of cellular and life-sustaining pathways.
Beyond enzyme regulation, Nebert's work extended significantly into teratology and metal toxicity. His laboratory developed and utilized multiple genetically engineered mouse models to trace how specific genes, such as SLC39A8 (ZIP8), mediate metal transport and guard against cadmium-induced disease. These specialized mouse models remain widely used across the biomedical and pharmaceutical industries for toxicological risk assessment.
Hub AI
Daniel W. Nebert AI simulator
(@Daniel W. Nebert_simulator)
Daniel W. Nebert
Daniel Walter Nebert is an American physician-scientist. He is a professor emeritus at the University of Cincinnati College of Medicine, where he spent the latter half of his academic career. His research has revolved around the central theme of gene–environment interactions.
He is widely known for foundational research in environmental molecular genetics, pharmacogenetics, and toxicology, particularly for discovering in 1974 the first evidence for, and naming of, the aryl hydrocarbon receptor (AHR), which was first shown to regulate levels of cytochrome P450 enzymes, but which today is known to be involved in many dozens of pathways critical to life. Ultimately, his pioneering work on the AHR receptor laid the foundation for modern ecogenetics, the study of how genetic variation dictates an individual's unique physiological responses to environmental toxicants and chemicals.
Nebert was raised in Oregon and comes from a family of Austrian-Bohemian ancestry. During his youth, he developed interests in science, music, golf, and academics, including piano training, song-writing, and participation in school publications and athletics, which he has later cited as formative influences on his disciplined scientific approach.
Nebert attended Wesleyan University, where he graduated with a Bachelor of Arts in Biochemistry. He then entered a five-year combined graduate and medical track at the University of Oregon Medical School, earning a Master of Science in Biophysics and a Doctor of Medicine in 1964. Following medical school, he completed a pediatric internship and residency at the University of California, Los Angeles (UCLA) Health Sciences Center from 1964 to 1966. Nebert subsequently served as a postdoctoral fellow from 1966 to 1968 at the National Cancer Institute, a component of the National Institutes of Health (NIH) in Bethesda, Maryland, where his research focused on oncology and cancer mechanisms.
Nebert began his independent scientific career at the National Institutes of Health (NIH) when he joined the National Institute of Child Health and Human Development (NICHD) in 1968. During his more than two decades at the NIH, he served as a section head and was later appointed Chief of the Laboratory of Developmental Pharmacology. While at the institute, Nebert conducted pioneering research on the genetic regulation of drug-metabolizing enzymes, establishing early experimental frameworks for studying how environmental chemicals interact with inherited genetic variation. To help formalize this emerging field, he organized and hosted a series of major international scientific symposia on drug-metabolizing enzymes and gene-environment interactions in 1985, 1987, and 1989.
In 1989, Nebert relocated to the University of Cincinnati Medical Center, where he was appointed Professor of Environmental Health. He also held a dual appointment as an adjunct professor in the Division of Human Genetics at the Cincinnati Children’s Hospital Medical Center. At the University of Cincinnati, Nebert founded the Center for Environmental Genetics (CEG) in 1992, serving as its director.The CEG became the first National Institute of Environmental Health Sciences (NIEHS)-designated Center of Excellence dedicated specifically to environmental genetics research, fostering interdisciplinary collaboration among geneticists, toxicologists, epidemiologists, and clinicians. Nebert remained active in research and institutional leadership at Cincinnati for 24 years until transitioning to professor emeritus status in 2013.
Nebert’s research has focused broadly on gene–environment interactions, establishing him as a foundational figure in ecogenetics. His laboratory was among the first to clone and characterize genes encoding cytochrome P450 enzymes, including CYP1A1, and to demonstrate how these genes are regulated by environmental exposures through the aryl hydrocarbon receptor (AHR). Nebert discovered the first experimental evidence for, and subsequently named, the AHR receptor in 1974. While initially shown to regulate cytochrome P450 levels, the receptor is now recognized as a critical regulator in dozens of cellular and life-sustaining pathways.
Beyond enzyme regulation, Nebert's work extended significantly into teratology and metal toxicity. His laboratory developed and utilized multiple genetically engineered mouse models to trace how specific genes, such as SLC39A8 (ZIP8), mediate metal transport and guard against cadmium-induced disease. These specialized mouse models remain widely used across the biomedical and pharmaceutical industries for toxicological risk assessment.
Recent media